National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968
A synthetic antisense oligodeoxynucleotide (AS ODN) targeting hypoxia-inducible factor-1alpha (HIF-1alpha) with potential antineoplastic activity. Anti-HIF-1alpha LNA antisense oligonucleotide EZN-2968 hybridizes with HIF-1alpha mRNA and blocks t HIF-1 alpha protein expression, which may result in the inhibition of angiogenesis, the inhibition of tumor cell proliferation, and apoptosis. HIF-1alpha, normally activated in response to hypoxia-induced stress, is a key transcription regulator of a large number of genes important in cellular adaptation to low-oxygen conditions, including angiogenesis, cell proliferation, apoptosis, and cell invasion. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:EZN-2968



Previous:anti-ErbB3 receptor monoclonal antibody MM-121, anti-FLT-1 ribozyme, anti-GP-3 monoclonal antibody, anti-HER3 monoclonal antibody U3-1287, anti-HGF monoclonal antibody SCH900105
Next:anti-human chorionic gonadotropin vaccine, anti-IGF-1 receptor human monoclonal antibody R1507, anti-IGF-1R fully human monoclonal antibody AMG-479, anti-IGF-1R recombinant monoclonal antibody BIIB022, anti-IGF-1R recombinant monoclonal antibody MK-0646

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov